Study to Evaluate the Efficacy and Safety of Telmisartan/Amlodipine/Rosuvastatin
Clinical trial NCT03088254 · COMPLETED
Trial details
- NCT number
- NCT03088254
- Sponsor
- Jeil Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-20
- Primary completion
- 2017-07-31
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.